COPD Trial, Recruiting NCT06084117 Sponsor: Franciscus Gasthuis Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06084117
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with chronic obstructive pulmonary disease (COPD), a long-term lung condition that makes breathing difficult
  • People who are currently experiencing a sudden worsening of their COPD where carbon dioxide has built up in the blood and the blood has become more acidic, confirmed by specific blood test results
  • People who are over 40 years old

Who may not be able to join:

  • People who have asthma
  • People whose doctor determines they urgently need a breathing tube inserted right away
  • People for whom neither of the two treatments being studied can be physically applied
  • People who are not expected to be able to give consent to participate, either straight away or later — for example, due to known memory or thinking problems, dementia, a serious active mental health condition, or significant intellectual disability
  • People who already use a breathing support machine at home (such as NIV or CPAP), or who have a known medical reason to use one — for example, sleep apnoea or a condition where obesity causes breathing problems during sleep
  • People who are expected to die very soon
  • People who have certain other serious conditions that may affect how well the treatments work, including a recent heart attack, fluid on the lungs caused by heart failure, or a large blood clot in the lungs — note that lung infections, which commonly cause COPD flare-ups, are not a reason for exclusion
  • People who have other serious conditions that would prevent safe participation, such as very unstable blood pressure requiring medication, severely reduced consciousness, or serious poisoning
  • People who have a surgically created opening in the throat for breathing (a tracheostomy)
  • People who are already taking part in another clinical trial involving a treatment or intervention
  • People who cannot be admitted to the intensive care unit or a closely monitored ward at the participating hospital
  • People who have previously stated clearly, verbally or in writing, that they do not want to take part in research
  • People whose blood bicarbonate level (a measure of the blood's chemistry) is below 20 mmol/L (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dorien Kiers, MD, PhD, Franciscus Gasthuis & Vlietland

Phone: +3110 461 6161

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Franciscus Gasthuis
Registry
ClinicalTrials.gov
Start date
14 May 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

feasilibity to perform a larger RCT inclusion rate; feasibility to perform a larger RCT screening rate; feasibility to perform a larger RCTperceived; feasibility to perform a larger RCT protocol deviations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov